U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Sold by Copeland Capital Management LLC

Copeland Capital Management LLC cut its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 2.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 816,272 shares of the company's stock after selling 23,084 shares during the quarter. Copeland Capital Management LLC owned about 5.37% of U.S. Physical Therapy worth $59,066,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in U.S. Physical Therapy by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 1,084,197 shares of the company's stock worth $96,179,000 after acquiring an additional 6,393 shares during the last quarter. Southernsun Asset Management LLC increased its stake in U.S. Physical Therapy by 4.5% during the fourth quarter. Southernsun Asset Management LLC now owns 571,809 shares of the company's stock worth $50,725,000 after acquiring an additional 24,698 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in U.S. Physical Therapy by 1.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 426,298 shares of the company's stock worth $37,818,000 after acquiring an additional 7,890 shares during the last quarter. Envestnet Asset Management Inc. increased its stake in U.S. Physical Therapy by 20.1% during the fourth quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company's stock worth $26,594,000 after acquiring an additional 50,163 shares during the last quarter. Finally, Northern Trust Corp increased its stake in U.S. Physical Therapy by 13.9% during the fourth quarter. Northern Trust Corp now owns 261,825 shares of the company's stock worth $23,226,000 after acquiring an additional 32,024 shares during the last quarter.

U.S. Physical Therapy Trading Up 0.6%

Shares of USPH opened at $79.13 on Friday. The company has a market capitalization of $1.20 billion, a P/E ratio of 36.30, a P/E/G ratio of 3.82 and a beta of 1.45. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.17 and a current ratio of 1.17. The stock has a 50-day moving average price of $74.89 and a 200 day moving average price of $80.06.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 EPS for the quarter, topping analysts' consensus estimates of $0.46 by $0.02. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. The firm had revenue of $183.79 million during the quarter, compared to the consensus estimate of $176.78 million. During the same quarter in the previous year, the company posted $0.51 earnings per share. The firm's revenue was up 18.0% on a year-over-year basis. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Shareholders of record on Friday, May 23rd were paid a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.27%. U.S. Physical Therapy's payout ratio is 82.57%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of the business's stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the sale, the director now owns 2,594 shares in the company, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on USPH. Wall Street Zen upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. JMP Securities reiterated a "market outperform" rating and issued a $113.00 target price on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Barrington Research lowered their target price on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research note on Friday, February 28th. Finally, JPMorgan Chase & Co. reduced their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.